首页> 外文期刊>Critical care medicine >Invasive Candida Infections and the Harm From Antibacterial Drugs in Critically III Patients: Data From a Randomized, Controlled Trial to Determine the Role of Ciprofloxacin, Piperacillin-Tazobactam Meropenem, and Cefuroxime
【24h】

Invasive Candida Infections and the Harm From Antibacterial Drugs in Critically III Patients: Data From a Randomized, Controlled Trial to Determine the Role of Ciprofloxacin, Piperacillin-Tazobactam Meropenem, and Cefuroxime

机译:严重的Ⅲ型患者的侵袭性念珠菌感染和抗菌药物的危害:来自一项确定环丙沙星,哌拉西林-他唑巴坦美罗培南和头孢呋辛酯作用的随机对照试验数据

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: Use of antibiotics in critically ill patients may increase the risk of invasive Candida infection. The objective of this study was to determine whether increased exposure to antibiotics is associated with increased prevalence of invasive Candida infection.
机译:目的:在重症患者中使用抗生素可能会增加侵袭性念珠菌感染的风险。这项研究的目的是确定增加与抗生素的接触是否与侵袭性念珠菌感染的增加有关。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号